Karyopharm Therapeutics Inc.
Hedge Funds Holdings
Last updated:
Karyopharm Therapeutics Inc.‘s stocks are currently a part of 128 hedge funds’ portfolios, which represents 66.51% of the total amount of its stocks outstanding. This makes up a total of 52.97M shares of Karyopharm Therapeutics Inc.. Compared to the previous quarter, the number fell by -21.10% or -14.16M shares fewer. As for the holding position changes, 42.97% (55) of current hedge fund investors increased the number of shares held, 28.91% (37) of current holders sold a part of the shares held, and 16.41% (21) closed the holdings completely. 16 hedge funds are new holders of Karyopharm Therapeutics Inc. stock in Q3 2022, it is 12.5% of total holders.
Hedge funds holding Karyopharm Therapeutics (Q4 2017 – Q3 2022)
| Q4 2017 | 89 |
|---|---|
| Q1 2018 | 88 |
| Q2 2018 | 108 |
| Q3 2018 | 119 |
| Q4 2018 | 116 |
| Q1 2019 | 106 |
| Q2 2019 | 101 |
| Q3 2019 | 105 |
| Q4 2019 | 145 |
| Q1 2020 | 135 |
| Q2 2020 | 152 |
| Q3 2020 | 155 |
| Q4 2020 | 166 |
| Q1 2021 | 168 |
| Q2 2021 | 150 |
| Q3 2021 | 132 |
| Q4 2021 | 139 |
| Q1 2022 | 134 |
| Q2 2022 | 143 |
| Q3 2022 | 128 |
Hedge funds changes in Karyopharm Therapeutics positions (Q4 2017 – Q3 2022)
| Q4 2017 | 18 | 32 | 24 | 6 | 9 |
|---|---|---|---|---|---|
| Q1 2018 | 13 | 39 | 21 | 13 | 2 |
| Q2 2018 | 33 | 42 | 21 | 11 | 1 |
| Q3 2018 | 18 | 34 | 38 | 8 | 21 |
| Q4 2018 | 15 | 50 | 36 | 16 | -1 |
| Q1 2019 | 16 | 43 | 21 | 25 | 1 |
| Q2 2019 | 17 | 38 | 30 | 18 | -2 |
| Q3 2019 | 25 | 40 | 25 | 22 | -7 |
| Q4 2019 | 52 | 41 | 39 | 11 | 2 |
| Q1 2020 | 28 | 56 | 37 | 35 | -21 |
| Q2 2020 | 42 | 65 | 32 | 23 | -10 |
| Q3 2020 | 29 | 54 | 53 | 25 | -6 |
| Q4 2020 | 31 | 61 | 44 | 21 | 9 |
| Q1 2021 | 28 | 58 | 56 | 25 | 1 |
| Q2 2021 | 21 | 53 | 54 | 38 | -16 |
| Q3 2021 | 14 | 58 | 32 | 33 | -5 |
| Q4 2021 | 27 | 52 | 45 | 19 | -4 |
| Q1 2022 | 24 | 44 | 44 | 28 | -6 |
| Q2 2022 | 26 | 41 | 58 | 13 | 5 |
| Q3 2022 | 16 | 55 | 37 | 21 | -1 |
Hedge funds changes in Karyopharm Therapeutics stock options (Q4 2017 – Q3 2022)
| Q4 2017 | 1,193,000 | 242,000 |
|---|---|---|
| Q1 2018 | 2,646,000 | 2,700,000 |
| Q2 2018 | 616,000 | 572,000 |
| Q3 2018 | 1,141,000 | 3,559,000 |
| Q4 2018 | 553,000 | 894,000 |
| Q1 2019 | 4,078,000 | 1,298,000 |
| Q2 2019 | 4,585,000 | 814,000 |
| Q3 2019 | 3,665,000 | 3,782,000 |
| Q4 2019 | 16,451,000 | 15,613,000 |
| Q1 2020 | 22,227,000 | 21,742,000 |
| Q2 2020 | 14,844,000 | 6,384,000 |
| Q3 2020 | 7,810,000 | 5,430,000 |
| Q4 2020 | 11,222,000 | 7,990,000 |
| Q1 2021 | 2,610,000 | 3,953,000 |
| Q2 2021 | 4,616,000 | 14,133,000 |
| Q3 2021 | 2,281,000 | 8,134,000 |
| Q4 2021 | 4,617,000 | 10,299,000 |
| Q1 2022 | 11,962,000 | 4,086,000 |
| Q2 2022 | 4,669,000 | 1,923,000 |
| Q3 2022 | 3,294,000 | 1,915,000 |